EF2K_HUMAN - dbPTM
EF2K_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EF2K_HUMAN
UniProt AC O00418
Protein Name Eukaryotic elongation factor 2 kinase
Gene Name EEF2K
Organism Homo sapiens (Human).
Sequence Length 725
Subcellular Localization
Protein Description Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced..
Protein Sequence MADEDLIFRLEGVDGGQSPRAGHDGDSDGDSDDEEGYFICPITDDPSSNQNVNSKVNKYYSNLTKSERYSSSGSPANSFHFKEAWKHAIQKAKHMPDPWAEFHLEDIATERATRHRYNAVTGEWLDDEVLIKMASQPFGRGAMRECFRTKKLSNFLHAQQWKGASNYVAKRYIEPVDRDVYFEDVRLQMEAKLWGEEYNRHKPPKQVDIMQMCIIELKDRPGKPLFHLEHYIEGKYIKYNSNSGFVRDDNIRLTPQAFSHFTFERSGHQLIVVDIQGVGDLYTDPQIHTETGTDFGDGNLGVRGMALFFYSHACNRICESMGLAPFDLSPRERDAVNQNTKLLQSAKTILRGTEEKCGSPQVRTLSGSRPPLLRPLSENSGDENMSDVTFDSLPSSPSSATPHSQKLDHLHWPVFSDLDNMASRDHDHLDNHRESENSGDSGYPSEKRGELDDPEPREHGHSYSNRKYESDEDSLGSSGRVCVEKWNLLNSSRLHLPRASAVALEVQRLNALDLEKKIGKSILGKVHLAMVRYHEGGRFCEKGEEWDQESAVFHLEHAANLGELEAIVGLGLMYSQLPHHILADVSLKETEENKTKGFDYLLKAAEAGDRQSMILVARAFDSGQNLSPDRCQDWLEALHWYNTALEMTDCDEGGEYDGMQDEPRYMMLAREAEMLFTGGYGLEKDPQRSGDLYTQAAEAAMEAMKGRLANQYYQKAEEAWAQMEE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADEDLIFR
------CCCCCEEEE
28.9722223895
18PhosphorylationEGVDGGQSPRAGHDG
ECCCCCCCCCCCCCC
21.4519664994
27PhosphorylationRAGHDGDSDGDSDDE
CCCCCCCCCCCCCCC
49.3626503892
31PhosphorylationDGDSDGDSDDEEGYF
CCCCCCCCCCCCCEE
53.1126503892
37PhosphorylationDSDDEEGYFICPITD
CCCCCCCEEEEECCC
7.9523927012
43PhosphorylationGYFICPITDDPSSNQ
CEEEEECCCCCCCCC
21.3523927012
47PhosphorylationCPITDDPSSNQNVNS
EECCCCCCCCCCHHH
49.2523927012
48PhosphorylationPITDDPSSNQNVNSK
ECCCCCCCCCCHHHH
48.0723927012
54PhosphorylationSSNQNVNSKVNKYYS
CCCCCHHHHHHHHHH
33.4323927012
58UbiquitinationNVNSKVNKYYSNLTK
CHHHHHHHHHHCCCH
48.8629967540
59PhosphorylationVNSKVNKYYSNLTKS
HHHHHHHHHHCCCHH
13.6128796482
60PhosphorylationNSKVNKYYSNLTKSE
HHHHHHHHHCCCHHH
7.8428796482
61PhosphorylationSKVNKYYSNLTKSER
HHHHHHHHCCCHHHH
23.4428796482
65UbiquitinationKYYSNLTKSERYSSS
HHHHCCCHHHHCCCC
54.1822817900
66PhosphorylationYYSNLTKSERYSSSG
HHHCCCHHHHCCCCC
23.2825159151
69PhosphorylationNLTKSERYSSSGSPA
CCCHHHHCCCCCCCC
14.6223927012
70PhosphorylationLTKSERYSSSGSPAN
CCHHHHCCCCCCCCC
25.0125463755
71PhosphorylationTKSERYSSSGSPANS
CHHHHCCCCCCCCCH
29.7725463755
72PhosphorylationKSERYSSSGSPANSF
HHHHCCCCCCCCCHH
37.0322167270
74PhosphorylationERYSSSGSPANSFHF
HHCCCCCCCCCHHHH
23.8422167270
78PhosphorylationSSGSPANSFHFKEAW
CCCCCCCHHHHHHHH
23.3915024086
82UbiquitinationPANSFHFKEAWKHAI
CCCHHHHHHHHHHHH
37.6429967540
86UbiquitinationFHFKEAWKHAIQKAK
HHHHHHHHHHHHHHH
30.1529967540
93UbiquitinationKHAIQKAKHMPDPWA
HHHHHHHHCCCCCCH
47.6929967540
132UbiquitinationLDDEVLIKMASQPFG
CCHHHHHHHHCCCCC
25.01-
135PhosphorylationEVLIKMASQPFGRGA
HHHHHHHCCCCCHHH
34.5822817900
151UbiquitinationRECFRTKKLSNFLHA
HHHHHHHHHHHHHHH
57.4429967540
162UbiquitinationFLHAQQWKGASNYVA
HHHHHHCCCCHHHHH
40.0221906983
170UbiquitinationGASNYVAKRYIEPVD
CCHHHHHHHHCCCCC
35.3729967540
178MethylationRYIEPVDRDVYFEDV
HHCCCCCCCCCHHHH
35.21-
202UbiquitinationGEEYNRHKPPKQVDI
HHHHHCCCCCCCCCE
60.8329967540
223UbiquitinationELKDRPGKPLFHLEH
EECCCCCCCCEEEEE
41.0329967540
235UbiquitinationLEHYIEGKYIKYNSN
EEEEECCEEEEECCC
30.8922817900
236PhosphorylationEHYIEGKYIKYNSNS
EEEECCEEEEECCCC
17.3222817900
238UbiquitinationYIEGKYIKYNSNSGF
EECCEEEEECCCCCC
34.9821890473
239PhosphorylationIEGKYIKYNSNSGFV
ECCEEEEECCCCCCC
17.7923312004
241PhosphorylationGKYIKYNSNSGFVRD
CEEEEECCCCCCCCC
29.3229214152
243PhosphorylationYIKYNSNSGFVRDDN
EEEECCCCCCCCCCC
33.1729214152
340PhosphorylationRDAVNQNTKLLQSAK
HHHHHHHHHHHHHHH
17.19-
341UbiquitinationDAVNQNTKLLQSAKT
HHHHHHHHHHHHHHH
55.5421906983
345PhosphorylationQNTKLLQSAKTILRG
HHHHHHHHHHHHHHC
31.5326055452
347UbiquitinationTKLLQSAKTILRGTE
HHHHHHHHHHHHCCH
41.1522817900
347AcetylationTKLLQSAKTILRGTE
HHHHHHHHHHHHCCH
41.1525953088
348PhosphorylationKLLQSAKTILRGTEE
HHHHHHHHHHHCCHH
25.5923401153
353PhosphorylationAKTILRGTEEKCGSP
HHHHHHCCHHHHCCC
34.2430266825
359PhosphorylationGTEEKCGSPQVRTLS
CCHHHHCCCCCCCCC
22.9430266825
364PhosphorylationCGSPQVRTLSGSRPP
HCCCCCCCCCCCCCC
26.8123909892
366PhosphorylationSPQVRTLSGSRPPLL
CCCCCCCCCCCCCCC
33.8215024086
368PhosphorylationQVRTLSGSRPPLLRP
CCCCCCCCCCCCCCC
37.9323312004
377PhosphorylationPPLLRPLSENSGDEN
CCCCCCCCCCCCCCC
37.1015024086
380PhosphorylationLRPLSENSGDENMSD
CCCCCCCCCCCCCCC
43.5023909892
386PhosphorylationNSGDENMSDVTFDSL
CCCCCCCCCCCCCCC
40.2825137130
389PhosphorylationDENMSDVTFDSLPSS
CCCCCCCCCCCCCCC
27.0725137130
392PhosphorylationMSDVTFDSLPSSPSS
CCCCCCCCCCCCCCC
37.6830576142
395PhosphorylationVTFDSLPSSPSSATP
CCCCCCCCCCCCCCC
61.2425137130
396PhosphorylationTFDSLPSSPSSATPH
CCCCCCCCCCCCCCC
27.1915024086
398PhosphorylationDSLPSSPSSATPHSQ
CCCCCCCCCCCCCCC
34.2615024086
399PhosphorylationSLPSSPSSATPHSQK
CCCCCCCCCCCCCCC
39.2830576142
401PhosphorylationPSSPSSATPHSQKLD
CCCCCCCCCCCCCCC
24.3926074081
404PhosphorylationPSSATPHSQKLDHLH
CCCCCCCCCCCCCCC
30.1627251275
416PhosphorylationHLHWPVFSDLDNMAS
CCCCCCCCCHHHHHH
37.18-
435PhosphorylationHLDNHRESENSGDSG
CHHCCCCCCCCCCCC
41.8723927012
438PhosphorylationNHRESENSGDSGYPS
CCCCCCCCCCCCCCC
39.6723927012
441PhosphorylationESENSGDSGYPSEKR
CCCCCCCCCCCCHHC
43.6923927012
443PhosphorylationENSGDSGYPSEKRGE
CCCCCCCCCCHHCCC
13.9223927012
445PhosphorylationSGDSGYPSEKRGELD
CCCCCCCCHHCCCCC
47.4623401153
447UbiquitinationDSGYPSEKRGELDDP
CCCCCCHHCCCCCCC
70.78-
462PhosphorylationEPREHGHSYSNRKYE
CCCCCCCCCCCCCCC
34.5430242111
464UbiquitinationREHGHSYSNRKYESD
CCCCCCCCCCCCCCC
32.9222053931
464PhosphorylationREHGHSYSNRKYESD
CCCCCCCCCCCCCCC
32.9227251275
467SumoylationGHSYSNRKYESDEDS
CCCCCCCCCCCCCCC
58.58-
467SumoylationGHSYSNRKYESDEDS
CCCCCCCCCCCCCCC
58.58-
468PhosphorylationHSYSNRKYESDEDSL
CCCCCCCCCCCCCCC
19.8922167270
470PhosphorylationYSNRKYESDEDSLGS
CCCCCCCCCCCCCCC
43.1222167270
474PhosphorylationKYESDEDSLGSSGRV
CCCCCCCCCCCCCCC
32.3622167270
477PhosphorylationSDEDSLGSSGRVCVE
CCCCCCCCCCCCHHH
34.6123927012
478PhosphorylationDEDSLGSSGRVCVEK
CCCCCCCCCCCHHHH
28.9023927012
485UbiquitinationSGRVCVEKWNLLNSS
CCCCHHHHHCCCCCC
22.4523000965
491PhosphorylationEKWNLLNSSRLHLPR
HHHCCCCCCCCCCCH
19.4625159151
492PhosphorylationKWNLLNSSRLHLPRA
HHCCCCCCCCCCCHH
37.4830576142
500PhosphorylationRLHLPRASAVALEVQ
CCCCCHHHHHHHHHH
25.2626329039
516UbiquitinationLNALDLEKKIGKSIL
HCCCCHHHHHCHHHH
57.92-
517UbiquitinationNALDLEKKIGKSILG
CCCCHHHHHCHHHHC
47.5229967540
520UbiquitinationDLEKKIGKSILGKVH
CHHHHHCHHHHCCCE
37.4829967540
521PhosphorylationLEKKIGKSILGKVHL
HHHHHCHHHHCCCEE
20.1721712546
582UbiquitinationSQLPHHILADVSLKE
HCCCHHHHCCCCCCC
2.6421890473
596UbiquitinationETEENKTKGFDYLLK
CCHHHHCCCHHHHHH
60.2229967540
600PhosphorylationNKTKGFDYLLKAAEA
HHCCCHHHHHHHHHC
16.2120068231
603UbiquitinationKGFDYLLKAAEAGDR
CCHHHHHHHHHCCCC
42.8521906983
622PhosphorylationLVARAFDSGQNLSPD
EEEEECCCCCCCCHH
35.5122468782
627PhosphorylationFDSGQNLSPDRCQDW
CCCCCCCCHHHHHHH
32.1021815630
684UbiquitinationTGGYGLEKDPQRSGD
HCCCCCCCCCCCCCC
78.6723503661
689PhosphorylationLEKDPQRSGDLYTQA
CCCCCCCCCCHHHHH
31.2629759185
693PhosphorylationPQRSGDLYTQAAEAA
CCCCCCHHHHHHHHH
11.1029759185
694PhosphorylationQRSGDLYTQAAEAAM
CCCCCHHHHHHHHHH
21.0128787133
705UbiquitinationEAAMEAMKGRLANQY
HHHHHHHHHHHHHHH
48.1823503661
712PhosphorylationKGRLANQYYQKAEEA
HHHHHHHHHHHHHHH
13.9927642862
713PhosphorylationGRLANQYYQKAEEAW
HHHHHHHHHHHHHHH
8.1827642862
715UbiquitinationLANQYYQKAEEAWAQ
HHHHHHHHHHHHHHH
41.46-
723SulfoxidationAEEAWAQMEE-----
HHHHHHHHCC-----
4.8930846556

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
61SPhosphorylationKinaseEEF2KO00418
PSP
66SPhosphorylationKinaseEEF2KO00418
PSP
72SPhosphorylationKinaseMTORP42345
PSP
74SPhosphorylationKinaseMTORP42345
PSP
78SPhosphorylationKinaseAMPK_GROUP-PhosphoELM
78SPhosphorylationKinaseCHAK1Q96QT4
PSP
78SPhosphorylationKinaseAMPK-FAMILY-GPS
78SPhosphorylationKinaseEEF2KO00418
PSP
348TPhosphorylationKinaseEEF2KO00418
PSP
353TPhosphorylationKinaseEEF2KO00418
PSP
359SPhosphorylationKinaseCDK1P06493
Uniprot
359SPhosphorylationKinaseMK13O15264
PhosphoELM
359SPhosphorylationKinaseP38DO15264
PSP
366SPhosphorylationKinaseRSK-SUBFAMILY-GPS
366SPhosphorylationKinaseAMPK_GROUP-PhosphoELM
366SPhosphorylationKinaseP70-SUBFAMILY-GPS
366SPhosphorylationKinaseAMPK-FAMILY-GPS
366SPhosphorylationKinaseEEF2KO00418
PSP
366SPhosphorylationKinaseP90RSKQ15418
PSP
366SPhosphorylationKinaseP70S6KP23443
PSP
366SPhosphorylationKinaseRPS6KB2Q9UBS0
GPS
366SPhosphorylationKinaseP70S6K_GROUP-PhosphoELM
366SPhosphorylationKinaseRSK_GROUP-PhosphoELM
377SPhosphorylationKinaseMAPKAPK3Q16644
GPS
377SPhosphorylationKinaseMAPKAPK5Q8IW41
GPS
377SPhosphorylationKinaseMAPK2P49137
PhosphoELM
396SPhosphorylationKinaseMAPK13O15264
GPS
396SPhosphorylationKinaseMAPK14Q16539
GPS
396SPhosphorylationKinaseMAPK11Q15759
GPS
396SPhosphorylationKinaseEEF2KO00418
PSP
398SPhosphorylationKinasePRKAA1Q13131
GPS
398SPhosphorylationKinaseAMPK_GROUP-PhosphoELM
398SPhosphorylationKinasePRKAA2P54646
GPS
398SPhosphorylationKinaseAMPK-FAMILY-GPS
398SPhosphorylationKinaseAMPKQ9Y478
Uniprot
441SPhosphorylationKinaseEEF2KO00418
PSP
445SPhosphorylationKinaseEEF2KO00418
PSP
474SPhosphorylationKinaseEEF2KO00418
PSP
491SPhosphorylationKinaseEEF2KO00418
PSP
500SPhosphorylationKinaseEEF2KO00418
PSP
500SPhosphorylationKinasePKA-Uniprot
-KUbiquitinationE3 ubiquitin ligaseBTRCQ9Y297
PMID:22669845

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
78SPhosphorylation

21112387
348TPhosphorylation

18669648
359SPhosphorylation

11500363
366SPhosphorylation

11500364
398SPhosphorylation

14709557

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EF2K_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FBW1A_HUMANBTRCphysical
22669845
SKP1_HUMANSKP1physical
22669845
EF2_HUMANEEF2physical
22669845
CDK1_HUMANCDK1physical
18337751
DENR_HUMANDENRphysical
18337751
ALBU_HUMANALBphysical
18337751
ACADV_HUMANACADVLphysical
18337751
MAP2_HUMANMETAP2physical
18337751
PA2G4_HUMANPA2G4physical
18337751
IF4A3_HUMANEIF4A3physical
18337751
ARP2_HUMANACTR2physical
22863883
CALR_HUMANCALRphysical
22863883
DPP9_HUMANDPP9physical
22863883
DUS3L_HUMANDUS3Lphysical
22863883
PANK4_HUMANPANK4physical
22863883
KAP1_HUMANPRKAR1Bphysical
22863883
RAGP1_HUMANRANGAP1physical
22863883
PRPK_HUMANTP53RKphysical
22863883
UBE3C_HUMANUBE3Cphysical
22863883
SRP14_HUMANSRP14physical
23455922
SRP09_HUMANSRP9physical
23455922
RAE1L_HUMANRAE1physical
23455922
ACACA_HUMANACACAphysical
23455922
WDFY3_HUMANWDFY3physical
23455922
FBW1B_HUMANFBXW11physical
23455922
FBW1A_HUMANBTRCphysical
23455922

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EF2K_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"The channel-kinase TRPM7 regulates phosphorylation of thetranslational factor eEF2 via eEF2-k.";
Perraud A.L., Zhao X., Ryazanov A.G., Schmitz C.;
Cell. Signal. 23:586-593(2011).
Cited for: PHOSPHORYLATION AT SER-78.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-470, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-27; SER-31;SER-470 AND SER-474, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; THR-348; SER-470;SER-474 AND SER-477, AND MASS SPECTROMETRY.
"cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- andamino acid-dependent manner.";
Smith E.M., Proud C.G.;
EMBO J. 27:1005-1016(2008).
Cited for: PHOSPHORYLATION AT SER-359.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-445, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-27; SER-31;TYR-69; SER-70; SER-470 AND SER-474, AND MASS SPECTROMETRY.
"Stimulation of the AMP-activated protein kinase leads to activationof eukaryotic elongation factor 2 kinase and to its phosphorylation ata novel site, serine 398.";
Browne G.J., Finn S.G., Proud C.G.;
J. Biol. Chem. 279:12220-12231(2004).
Cited for: FUNCTION, AND PHOSPHORYLATION AT SER-398.
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry.";
Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.;
Anal. Chem. 76:2763-2772(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY.
"Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6kinase.";
Wang X., Li W., Williams M., Terada N., Alessi D.R., Proud C.G.;
EMBO J. 20:4370-4379(2001).
Cited for: PHOSPHORYLATION AT SER-366 BY RPS6KA1 AND RPS6KB1, AND MUTAGENESIS OFSER-366.
"A novel method to identify protein kinase substrates: eEF2 kinase isphosphorylated and inhibited by SAPK4/p38delta.";
Knebel A., Morrice N., Cohen P.;
EMBO J. 20:4360-4369(2001).
Cited for: PHOSPHORYLATION AT SER-359.

TOP